AT

ATUM CO., LTD.

Bioengineering solutions to accelerate life sciences research, from gene synthesis to cell lines.

355690 | KO

Overview

Corporate Details

ISIN(s):
KR7355690009
LEI:
Country:
South Korea
Address:
서울특별시 구로구 디지털로31길 38-9 에이스테크노타워1차 6층 603-2호, 구로구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ATUM is a biotechnology company that provides integrated solutions and tools for the life sciences industry. Specializing in advanced bioengineering, the company offers services designed to accelerate timelines from discovery and preclinical research to manufacturing and Investigational New Drug (IND) applications. Its core offerings include gene design and synthesis, vector and sequence optimization, protein engineering, and the development of high-producing cell lines. Founded as DNA2.0 in 2003, ATUM operates on a collaborative model, partnering with researchers to advance their projects in molecular biology and protein engineering.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-07-29 00:00
Capital/Financing Update
타인에대한채무보증결정
Korean 10.4 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.8 MB
2025-05-07 00:00
M&A Activity
합병등종료보고서(자산양수도)
Korean 15.1 KB
2025-05-02 00:00
Capital/Financing Update
단기차입금증가결정
Korean 9.4 KB
2025-04-29 00:00
Share Issue/Capital Change
주요사항보고서(전환사채권발행결정)
Korean 65.7 KB
2025-04-29 00:00
M&A Activity
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
Korean 57.6 KB
2025-04-29 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 70.0 KB
2025-04-29 00:00
Share Issue/Capital Change
증권발행결과(자율공시) (제4회차 CB)
Korean 6.0 KB
2025-04-02 00:00
M&A Activity
합병등종료보고서(자산양수도)
Korean 14.9 KB
2025-04-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-03-31 00:00
M&A Activity
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
Korean 49.2 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 23.9 KB
2025-03-28 00:00
Regulatory News Service
본점소재지변경
Korean 5.0 KB
2025-03-21 00:00
M&A Activity
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
Korean 49.3 KB

Automate Your Workflow. Get a real-time feed of all ATUM CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ATUM CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ATUM CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GILEAD SCIENCES, INC. Logo
Develops innovative medicines for life-threatening diseases in virology, oncology & inflammation.
United States of America
GILD
GlaxoSmithKline PLC Logo
A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.
United Kingdom
GSK
GL Pharm Tech Corp. Logo
Develops improved drugs and generics, and licenses proprietary drug formulation technologies.
South Korea
204840
GNI  Group Ltd. Logo
Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.
Japan
2160
Goodwill Pharma Plc Logo
Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.
Hungary
GWPH
Gossamer Bio, Inc. Logo
Clinical-stage biopharma developing inhaled therapies for rare pulmonary hypertension.
United States of America
GOSS
Grace Therapeutics, Inc. Logo
Develops improved drugs for rare neurological diseases using novel drug delivery technologies.
United States of America
GRCE
A biotech firm in biopharma, diagnostics, digital health, and consumer wellness products.
South Korea
005250
GREEN CROSS WellBeing Corporation Logo
Develops personalized nutrition solutions, from prescription injections to supplements & cosmetics.
South Korea
234690
Greenwich LifeSciences, Inc. Logo
Developing an immunotherapy vaccine to prevent recurrence in HER2-positive breast cancer patients.
United States of America
GLSI

Talk to a Data Expert

Have a question? We'll get back to you promptly.